Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells
Lloviu virus (LLOV) is a new member of the filovirus family that also includes Ebola virus (EBOV) and Marburg virus (MARV). LLOV has not been cultured; however, its genomic RNA sequence indicates the coding capacity to produce homologs of the EBOV and MARV VP24, VP35, and VP40 proteins. EBOV and MARV VP35 proteins inhibit interferon (IFN)-alpha/beta production and EBOV VP35 blocks activation of the antiviral kinase PKR. The EBOV VP24 and MARV VP40 proteins inhibit IFN signaling, albeit by different mechanisms. Here we demonstrate that LLOV VP35 suppresses Sendai virus induced IFN regulatory factor 3 (IRF3) phosphorylation, IFN-α/β production, and PKR phosphorylation. Additionally, LLOV VP24 blocks tyrosine phosphorylated STAT1 binding to karyopherin alpha 5 (KPNA5), STAT1 nuclear accumulation, and IFN-induced gene expression. LLOV VP40 lacks detectable IFN antagonist function. These activities parallel EBOV IFN inhibitory functions. EBOV and LLOV VP35 and VP24 proteins also inhibit IFN responses in bat cells. These data suggest that LLOV infection will block innate immune responses in a manner similar to EBOV..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:485 |
|---|---|
| Enthalten in: |
Virology - 485(2015), Seite 145-152 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Feagins, Alicia R [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: |
|---|
| RVK: |
|---|
| doi: |
10.1016/j.virol.2015.07.010 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1963959957 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1963959957 | ||
| 003 | DE-627 | ||
| 005 | 20230518205325.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.virol.2015.07.010 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1963959957 | ||
| 035 | |a (DE-599)GBVOLC1963959957 | ||
| 035 | |a (PRQ)c1274-e0837349b982e020c82dbfb0a2a10886539f61caa3c33a1186df20b0c1b16b070 | ||
| 035 | |a (KEY)0023936420150000485000000145lloviuvirusvp24andvp35proteinsfunctionasinnateimmu | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |a 610 |q DNB |
| 084 | |a WA 15000 |q AVZ |2 rvk | ||
| 084 | |a 44.43 |2 bkl | ||
| 100 | 1 | |a Feagins, Alicia R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Lloviu virus (LLOV) is a new member of the filovirus family that also includes Ebola virus (EBOV) and Marburg virus (MARV). LLOV has not been cultured; however, its genomic RNA sequence indicates the coding capacity to produce homologs of the EBOV and MARV VP24, VP35, and VP40 proteins. EBOV and MARV VP35 proteins inhibit interferon (IFN)-alpha/beta production and EBOV VP35 blocks activation of the antiviral kinase PKR. The EBOV VP24 and MARV VP40 proteins inhibit IFN signaling, albeit by different mechanisms. Here we demonstrate that LLOV VP35 suppresses Sendai virus induced IFN regulatory factor 3 (IRF3) phosphorylation, IFN-α/β production, and PKR phosphorylation. Additionally, LLOV VP24 blocks tyrosine phosphorylated STAT1 binding to karyopherin alpha 5 (KPNA5), STAT1 nuclear accumulation, and IFN-induced gene expression. LLOV VP40 lacks detectable IFN antagonist function. These activities parallel EBOV IFN inhibitory functions. EBOV and LLOV VP35 and VP24 proteins also inhibit IFN responses in bat cells. These data suggest that LLOV infection will block innate immune responses in a manner similar to EBOV. | ||
| 540 | |a Nutzungsrecht: Copyright © 2015 Elsevier Inc. All rights reserved. | ||
| 700 | 1 | |a Basler, Christopher F |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Virology |d San Diego, Calif. [u.a.] : Elsevier, 1955 |g 485(2015), Seite 145-152 |w (DE-627)129459798 |w (DE-600)200425-2 |w (DE-576)014823659 |x 0042-6822 |7 nnns |
| 773 | 1 | 8 | |g volume:485 |g year:2015 |g pages:145-152 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1016/j.virol.2015.07.010 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26255028 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-VET | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_2015 | ||
| 912 | |a GBV_ILN_2219 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | r | v | |a WA 15000 |
| 936 | b | k | |a 44.43 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 485 |j 2015 |h 145-152 | ||